Gammadiagnostics
1 known investors
Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.
Founders & leadership
DD
Dr. Dave FarrellFounder and CSO
Investors Β· 1
Frequently asked questions
- What does Gammadiagnostics do?
- Gamma Diagnostics develops diagnostic tests based on Gamma Prime Fibrinogen (GPF), a blood biomarker for assessing inflammation and predicting cardiovascular and infectious disease outcomes. The company serves clinicians and healthcare providers seeking improved patient risk stratification and treatment planning.
- Who founded Gammadiagnostics?
- Gammadiagnostics was founded by Dr. Dave Farrell.
- Who are Gammadiagnostics's investors?
- Gammadiagnostics's investors include Expert DOJO.